Use of Electronic Vapor Products Before, During, and After Pregnancy Among Women with a Recent Live Birth - Oklahoma and Texas, 2015.
Use of Electronic Vapor Products Before, During, and After Pregnancy Among Women with a Recent Live Birth - Oklahoma and Texas, 2015.
复制标题
DOI：
10.15585/mmwr.mm6808a1
复制
发表时间：
2019-03-01
期刊：
影响因子：
--
通讯作者：
King, Brian A
中科院分区：
文献类型：
--
作者：
Kapaya, Martha;D'Angelo, Denise V;King, Brian A
电子烟产品 (EVP) 包括多种设备，包括电子烟 (e-香烟)。 EVP 用户吸入通常含有尼古丁、调味剂和其他添加剂的气雾剂 (1)。尼古丁是一种发育毒物，会对妊娠和婴儿结局产生不利影响 (2)。对俄克拉荷马州和德克萨斯州 2015 年妊娠风险评估监测系统 (PRAMS) 的数据进行了分析，以估计近期活产妇女中基于人群的 EVP 使用情况。对怀孕前（定义为怀孕前>3个月）和怀孕前后（定义为怀孕前3个月、怀孕最后3个月或产后2-6个月期间的任何时间）使用EVP、使用EVP的原因以及同时使用EVP和香烟进行了评估。怀孕前 EVP 使用率为 10.4%，怀孕前后为 7.0%，其中怀孕最后 3 个月为 1.4%。在怀孕最后 3 个月使用 EVP 的女性中，38.4% 的女性报告使用含有尼古丁的 EVP，26.4% 的女性不确定尼古丁含量。在使用过EVP和香烟的女性中，怀孕前3个月双重使用率为38.0%，怀孕最后3个月为7.7%，产后2-6个月为11.8%。怀孕期间使用 EVP 最常见的原因是好奇（54.0%）、认为 EVP 可能有助于戒烟或减少吸烟（45.2%），以及与吸烟相比，减少对母亲的伤害（45.2%）。需要明确的信息表明，怀孕期间使用 EVP 并不安全，并且需要提供广泛、无障碍的循证戒烟策略。
Electronic vapor products (EVPs) comprise a diverse group of devices, including electronic cigarettes (e-cigarettes). EVP users inhale an aerosol that typically contains nicotine, flavorings, and other additives (1). Nicotine is a developmental toxicant that adversely affects pregnancy and infant outcomes (2). Data from the 2015 Pregnancy Risk Assessment Monitoring System (PRAMS) for Oklahoma and Texas were analyzed to estimate population-based EVP use among women with a recent live birth. EVP use before pregnancy (defined as >3 months before pregnancy) and around the time of pregnancy (defined as any time during the 3 months before pregnancy, the last 3 months of pregnancy, or 2-6 months after delivery), reasons for EVP use, and dual use of EVPs and cigarettes were assessed. Prevalence of EVP use was 10.4% before pregnancy and 7.0% around the time of pregnancy, including 1.4% during the last 3 months of pregnancy. Among women using EVPs during the last 3 months of pregnancy, 38.4% reported use of EVPs containing nicotine, and 26.4% were unsure of nicotine content. Among women who had used EVPs and cigarettes, dual use prevalence was 38.0% in the 3 months before pregnancy, 7.7% during the last 3 months of pregnancy, and 11.8% in the 2-6 months after delivery. The most frequently reported reasons for EVP use around the time of pregnancy were curiosity (54.0%), the perception that EVPs might help with quitting or reducing cigarette smoking (45.2%), and the perception of reduced harm to the mother, when compared with cigarette smoking (45.2%). Clear messages that EVP use is not safe during pregnancy are needed, and broad, barrier-free access to evidence-based tobacco cessation strategies need to be made available.